Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vascular ATP-sensitive potassium (K_ATP) channel is a hetero-octameric protein complex that serves as a key regulator of vascular tone by coupling cellular metabolism to membrane excitability [PubMed, 2012]. In vascular smooth muscle, this channel is primarily composed of four pore-forming inward-rectifier potassium channel 6.1 (Kir6.1) subunits and four regulatory sulfonylurea receptor 2B (SUR2B) subunits [UniProt, 2024]. The channel's activity is modulated by the intracellular ATP/ADP ratio; a decrease in ATP or an increase in ADP, often occurring during hypoxia or metabolic stress, promotes channel opening [NCBI, 2010]. Opening of the K_ATP channel allows potassium ions to flow out of the cell, leading to membrane hyperpolarization and the subsequent closure of voltage-gated L-type calcium channels [StatPearls, 2023]. This reduction in calcium influx results in smooth muscle relaxation and vasodilation, effectively lowering peripheral vascular resistance and blood pressure [PubMed, 2017]. Pharmacologically, K_ATP channel openers like minoxidil and nicorandil are utilized in the management of refractory hypertension and angina, while gain-of-function mutations in the constituent subunits are the underlying cause of Cantú syndrome [NIH, 2021]. Conversely, non-selective sulfonylureas used in diabetes, such as glibenclamide, can inhibit these channels, potentially impacting vascular reactivity [PubChem, 2024].
Activation of the channel leads to potassium efflux and membrane hyperpolarization, which inhibits voltage-gated calcium channels, reducing intracellular calcium and causing vascular smooth muscle relaxation [StatPearls, 2023].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular ATP-sensitive potassium channel (K_ATP) (K_ATP).